The Official Website for The Nemechek Protocol™ Medical Recovery Program

Dr. Nemechek will be Presenting Research in Scotland at the 13th INS Congress

Dr. Nemechek will be Presenting Research in Scotland at the 13th INS Congress
May 30, 2017 Dr. Patrick Nemechek and Jean Nemechek

13th International Neuromodulation Conference

I will be presenting more of my research at the most important brain stimulation conference of the year, the 13th International Neuromodulation Conference in Edinburgh, Scotland.

My first presentation on Monday, May 29th is historic. I will be presenting the largest single case series of autonomic recovery ever recorded in humans, 76 subjects. Each subject was started on The Nemechek Protocol for Autonomic Recovery and within 2-4 months experienced reversal of their autonomic dysfunction. The following is a video screencast of the presentation I will be giving in its entirety at the conference.


ANS Recovery – INS Congress, Scotland 2017

At present, recovery of chronic brain damage is considered impossible. The Nemechek Protocol for Autonomic Recovery is the first regimen potent enough to overcoming the underlying inflammation and abnormal microglia function that impede brain recovery from concussions, emotional trauma, and inflammatory stress such as surgery, fractures or vaccines.


The Potency of Vagus Nerve Stimulation

While all aspects of the protocol are required for recovery in most subjects, the transcutaneous application of vagus nerve stimulation (VNS) is the single most potent element in the regimen.

By applying a mild electrical current to the tragus or concha for a few hours per day, the brain is induced to repair damaged or missing neuronal pathways though a natural process called neuroplasticity.

Bioelectrical therapy in the form of vagus nerve stimulation is poised to radically change how many inflammation-based disorders are treated.

Dr. Kevin Tracey has pioneered the basic scientific discoveries and development behind VNS, and believes VNS holds the potential to replace 50% of all prescription medications within the next several decades.


Reversal of Alzheimer’s Dementia

My second oral presentation is equally important. It is only the second report of full clinical recovery of moderately severe Alzheimer’s dementia. These 2 male subjects underwent The Nemechek Protocol, modified for the unique inflammatory issues responsible for Alzheimer’s dementia.

Both subjects suffered from such severe dementia that they were incapable of communicating their medical history to me on their first visit. Within 5 months, both subjects could easily and correctly relate recent events in their lives, and could travel to our visits unaided by family members. The following is a video screencast of the presentation I will be giving in its entirety.


Alzheimer Reversal – INS Congress, Scotland 2017


Combat-Associated Post Traumatic Stress Disorder (PTSD)

And third, I will be making a poster presentation on the recovery of combat-induced PTSD. A poster presentation is a unique experience where researchers interested in your research topic can speak with you one-on-one about your findings.

PTSD, Alzheimer’s dementia and chronic autonomic damage all share a common pathological process, the excessive production of pro-inflammatory cytokines fueled by primed-microglia. Although I did not give an oral presentation on my work with PTSD, I have prepared a similar video for you explaining my findings and work.


Reversal of Combat-Associated PTSD – INS Congress, Scotland 2017


Links to download and view the PTSD poster as well as those associated with my oral presentations are listed below. You will need Adobe Viewer to view these files.

PTSD Recovery – INS Congress, Scotland 2017
Autonomic Recovery – INS Congress, Scotland 2017
Alzheimer’s Dementia Recovery – INS Congress, Scotland 2017

This post is provided as an information resource only, and is not to be used or relied on for any diagnostic or treatment purposes. This information is not intended to be patient education, and does not create any patient-physician relationship.

© 2017. Dr. Patrick M. Nemechek and Jean R. Nemechek. All Rights Reserved. Patent Pending.


  1. Patrick Nemechek, D.O. 4 months ago

    No, I’m sorry we don’t.

  2. Jo 4 months ago

    Do you have an practitioners for Nemechek in the UK yet please? Thanks..

  3. Patrick Nemechek, D.O. 6 months ago

    I am unaware of any papers describing microglial activation from aluminum adjuvants.

    The main point is that if a child has normal unprimed microglia because they never had significant bacterial overgrowth, then the immune stimulation from vaccines has only a temporary effect and the brain recovers.

    Our present problem as I see it is that so many children (and adults) today have primed microglia from significant intestinal dysbiosis, excessive exposure to omega-6 fatty acids, and even exposure to diesel fumes (in the slums of large cities) that the immune stimulation is causing greater neurological damage and limits recovery.

    This sets the stage for increases in propionic acid production leading to the features of autism, more profound and treatment-resistant developmental delay and cumulative brain injury leading to hyperactivity, anxiousness, chronic depression and learning disorders (ADD).

  4. Andrew 6 months ago

    I note that you have commented that vaccines can cause brain injury- a position I agree with.
    There is ample evidence of microglial activation and IL-6 mediated brain inflamation following the injection of aluminium adjuvant in mice.
    Leaving aside the question of whether we should be using aluminium adjuvants at all– do you think that there may be a role for short term use of the protocol post vaccine or other brain insults?

  5. Patrick Nemechek, D.O. 7 months ago

    No, all of them were no longer seeing counselors.

    Success was based upon clinical resolution of autonomic dysfunction as well as resolution of depression and PTSD triggers and flashbacks.

  6. Milly 7 months ago

    Are your PTSD clients/ patients looked after by other health professional at the same time as they are on the protocol?

    And if so how did you measure who/ or what was more successful in the “curing” of your patients?

  7. Patrick Nemechek, D.O. 12 months ago

    We’re adding alot of that information within the eBook that will be out shortly.

  8. Ken 12 months ago

    Sounds great, may I request a blog post with more detail on the topics of inflammatory microglia, their relation to CFS/ME development or symptoms, and the protocol if there’s knowledge you can share on the topics.

  9. Patrick Nemechek, D.O. 1 year ago


    Recent studies are demonstrating that CFS/ME is hyperactivated microglia condition as well. I have used my protocol with great success in these patients.

  10. Ken 1 year ago

    Interesting content on the recovery of these cases.

    What are your thoughts on the applicability of such a protocol in the treatment or management of CFS/ME? It seems that many patients get worse after a bout of illness/trauma but not necessarily a physical brain injury.

Leave a reply

Your email address will not be published.

Send this to friend